Thursday, September 10, 2026

Centers for Deception Control

 The role and effectiveness of the Epidemic Intelligence Service (EIS), a little-known branch of the Centers for Disease Control and Prevention (CDC), during critical public health crises, particularly regarding the COVID-19 pandemic. The author raises concerns about leadership and transparency within the CDC and the EIS.

1. Epidemic Intelligence Service Overview: The EIS is often referred to as CDC's "disease detectives" and has a long history of addressing public health threats globally. However, it is notably absent from the CDC's main organizational structure.

2. Historical Context: The EIS has been integral in fighting diseases throughout its 75-year history, including the Smallpox Eradication Program and recent measles outbreaks. The COVID-19 pandemic is a key omission in EIS’s historical contributions, leading to questions regarding the agency’s effectiveness.

3. Key Figures: Dr. Anne Schuchat, a significant figure in the CDC, has been praised for her competence, though she was involved in the agency during crucial moments of the pandemic. Dr. Nancy Messonnier, another prominent CDC official, provided scripted communications during the early COVID-19 pandemic, drawing attention to the coordination and messaging strategies used.

4. Scrutiny of Leadership: The article discusses a Congressional inquiry into Messonnier's actions during the pandemic. She was accompanied by lawyers during her testimony, highlighting concerns over accountability. Key questions include if there was any interference from President Trump and the overall effectiveness of the CDC's response.

5. Questions About the EIS: The author calls for transparency regarding the EIS’s involvement in pandemic response, including whether officials were aware of and actively participated in gain-of-function research at the Wuhan Institute of Virology, which has been a point of contention regarding the origins of COVID-19.

6. Critique of CDC and EIS: The article characterizes the CDC as possibly misleading the public about its operations and efficacy, denoting a need for a reevaluation of the agency’s purpose and structure.

The article concludes with a plea for accountability from Congress regarding both the CDC and EIS. It emphasizes the need for transparency in public health communication and criticism of the agencies' past missteps during the COVID-19 crisis. The author suggests rebranding the CDC to reflect a perceived lack of truthfulness in its operations. 

https://www.americanthinker.com/articles/2026/09/centers-for-deception-control/

No comments: